Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 155 articles:
HTML format



Single Articles


    July 2021
  1. WARREN KJ, Poole JA, Sweeter JM, DeVasure JM, et al
    Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation.
    Respir Res. 2021;22:206.
    PubMed     Abstract available


  2. O'BEIRNE SL, Salit J, Kaner RJ, Crystal RG, et al
    Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
    Respir Res. 2021;22:200.
    PubMed     Abstract available


    June 2021
  3. PAPAKONSTANTINOU E, Koletsa T, Zhou L, Fang L, et al
    Bronchial thermoplasty in asthma: an exploratory histopathological evaluation in distinct asthma endotypes/phenotypes.
    Respir Res. 2021;22:186.
    PubMed     Abstract available


  4. LEMIERE C, Taille C, Lee JK, Smith SG, et al
    Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials.
    Respir Res. 2021;22:184.
    PubMed     Abstract available


  5. MO Y, Ye L, Cai H, Zhu G, et al
    SERPINB10 contributes to asthma by inhibiting the apoptosis of allergenic Th2 cells.
    Respir Res. 2021;22:178.
    PubMed     Abstract available


  6. WARDZYNSKA A, Pawelczyk M, Rywaniak J, Makowska J, et al
    Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation.
    Respir Res. 2021;22:177.
    PubMed     Abstract available


  7. GIBSON PG, Prazma CM, Chupp GL, Bradford ES, et al
    Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.
    Respir Res. 2021;22:171.
    PubMed     Abstract available


  8. ABDO M, Uddin M, Goldmann T, Marwitz S, et al
    Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma.
    Respir Res. 2021;22:167.
    PubMed     Abstract available


  9. KUROKAWA A, Kondo M, Arimura K, Ashino S, et al
    Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice.
    Respir Res. 2021;22:166.
    PubMed     Abstract available


    May 2021
  10. PADILLA-GALO A, Garcia-Ruiz AJ, Levy Abitbol RC, Olveira C, et al
    Real-life cost-effectiveness of benralizumab in patients with severe asthma.
    Respir Res. 2021;22:163.
    PubMed     Abstract available


  11. LAMB D, De Sousa D, Quast K, Fundel-Clemens K, et al
    RORgammat inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.
    Respir Res. 2021;22:158.
    PubMed     Abstract available


  12. PERTZOV B, Ronen M, Rosengarten D, Shitenberg D, et al
    Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients.
    Respir Res. 2021;22:154.
    PubMed     Abstract available


  13. LIU MC, Chipps B, Munoz X, Devouassoux G, et al
    Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
    Respir Res. 2021;22:144.
    PubMed     Abstract available


  14. WANG T, Zhou Y, Kong N, Zhang J, et al
    Weight gain from early to middle adulthood increases the risk of incident asthma later in life in the United States: a retrospective cohort study.
    Respir Res. 2021;22:139.
    PubMed     Abstract available


  15. RAHERISON-SEMJEN C, Parrat E, Nocent-Eijnani C, Mangiapan G, et al
    FASE-CPHG Study: identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis.
    Respir Res. 2021;22:136.
    PubMed     Abstract available


    April 2021
  16. CHEN A, Diaz-Soto MP, Sanmamed MF, Adams T, et al
    Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma.
    Respir Res. 2021;22:122.
    PubMed     Abstract available


  17. WORTH H, Criee CP, Vogelmeier CF, Kardos P, et al
    Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
    Respir Res. 2021;22:108.
    PubMed     Abstract available


  18. SADATSAFAVI M, Khakban A, Tavakoli H, Ehteshami-Afshar S, et al
    Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.
    Respir Res. 2021;22:103.
    PubMed     Abstract available


    March 2021
  19. SHAHANGIAN K, Ngan DA, Chen HHR, Oh Y, et al
    IL-4Ralpha blockade reduces influenza-associated morbidity in a murine model of allergic asthma.
    Respir Res. 2021;22:75.
    PubMed     Abstract available


    February 2021
  20. WU TD, Fawzy A, Kinney GL, Bon J, et al
    Metformin use and respiratory outcomes in asthma-COPD overlap.
    Respir Res. 2021;22:70.
    PubMed     Abstract available


  21. CALMES D, Huynen P, Paulus V, Henket M, et al
    Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype.
    Respir Res. 2021;22:72.
    PubMed     Abstract available


  22. BEKAERT S, Rocks N, Vanwinge C, Noel A, et al
    Asthma-related inflammation promotes lung metastasis of breast cancer cells through CCL11-CCR3 pathway.
    Respir Res. 2021;22:61.
    PubMed     Abstract available


  23. KERMANI NZ, Song WJ, Badi Y, Versi A, et al
    Correction to: Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
    Respir Res. 2021;22:47.
    PubMed    


  24. HU Y, Chen Y, Liu S, Jiang F, et al
    Breastfeeding duration modified the effects of neonatal and familial risk factors on childhood asthma and allergy: a population-based study.
    Respir Res. 2021;22:41.
    PubMed     Abstract available


  25. TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
    Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
    Respir Res. 2021;22:35.
    PubMed     Abstract available


    January 2021
  26. FENG Z, Wang J, Xie Y, Li J, et al
    Effects of exercise-based pulmonary rehabilitation on adults with asthma: a systematic review and meta-analysis.
    Respir Res. 2021;22:33.
    PubMed     Abstract available


  27. SCHLEICH F, Graff S, Guissard F, Henket M, et al
    Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping.
    Respir Res. 2021;22:15.
    PubMed     Abstract available


  28. KERMANI NZ, Song WJ, Badi Y, Versi A, et al
    Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
    Respir Res. 2021;22:10.
    PubMed     Abstract available


    November 2020
  29. ALNAJEM A, Redha A, Alroumi D, Alshammasi A, et al
    Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study.
    Respir Res. 2020;21:300.
    PubMed     Abstract available


    October 2020
  30. SINGH D, Virchow JC, Canonica GW, Vele A, et al
    Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER.
    Respir Res. 2020;21:285.
    PubMed     Abstract available


  31. ABDO M, Watz H, Veith V, Kirsten AM, et al
    Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study.
    Respir Res. 2020;21:278.
    PubMed     Abstract available


  32. MENZIES-GOW A, Ponnarambil S, Downie J, Bowen K, et al
    DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Respir Res. 2020;21:279.
    PubMed     Abstract available


  33. GROTH EE, Weber M, Bahmer T, Pedersen F, et al
    Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0.
    Respir Res. 2020;21:274.
    PubMed     Abstract available


  34. MENZIES-GOW A, Wechsler ME, Brightling CE
    Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
    Respir Res. 2020;21:268.
    PubMed     Abstract available


  35. MENZIES-GOW A, Colice G, Griffiths JM, Almqvist G, et al
    NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Respir Res. 2020;21:266.
    PubMed     Abstract available


  36. WECHSLER ME, Colice G, Griffiths JM, Almqvist G, et al
    SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
    Respir Res. 2020;21:264.
    PubMed     Abstract available


  37. EMSON C, Diver S, Chachi L, Megally A, et al
    CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
    Respir Res. 2020;21:265.
    PubMed     Abstract available


    September 2020
  38. MATUSIAK M, Schurch CM
    Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics.
    Respir Res. 2020;21:252.
    PubMed     Abstract available


  39. MILLER D, Vaidya S, Jauernig J, Ethell B, et al
    Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients.
    Respir Res. 2020;21:248.
    PubMed     Abstract available


  40. GAO P, Tang K, Lu Y, Huang Z, et al
    Pentraxin 3 promotes airway inflammation in experimental asthma.
    Respir Res. 2020;21:237.
    PubMed     Abstract available


  41. JIMENEZ E, Astbury C, Albayaty M, Wahlby-Hamren U, et al
    Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacolog
    Respir Res. 2020;21.
    PubMed     Abstract available


    August 2020
  42. SUGAWARA H, Saito A, Yokoyama S, Tsunematsu K, et al
    A retrospective analysis of usefulness of impulse oscillometry system in the treatment of asthma.
    Respir Res. 2020;21:226.
    PubMed     Abstract available


  43. GRAFF S, Vanwynsberghe S, Brusselle G, Hanon S, et al
    Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry.
    Respir Res. 2020;21:214.
    PubMed     Abstract available


    July 2020
  44. TOMMOLA M, Won HK, Ilmarinen P, Jung H, et al
    Relationship between age and bronchodilator response at diagnosis in adult-onset asthma.
    Respir Res. 2020;21:179.
    PubMed     Abstract available


  45. VELLA G, Lunding L, Ritzmann F, Honecker A, et al
    The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma.
    Respir Res. 2020;21:176.
    PubMed     Abstract available


  46. ZHANG J, Zhu Z, Zuo X, Pan H, et al
    The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma.
    Respir Res. 2020;21:170.
    PubMed     Abstract available


  47. ABDULNASSER HARFOUSH S, Hannig M, Le DD, Heck S, et al
    High-dose intranasal application of titanium dioxide nanoparticles induces the systemic uptakes and allergic airway inflammation in asthmatic mice.
    Respir Res. 2020;21:168.
    PubMed     Abstract available


    June 2020
  48. KERWIN E, Pascoe S, Bailes Z, Nathan R, et al
    A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
    Respir Res. 2020;21:148.
    PubMed     Abstract available


    May 2020
  49. GHOSH N, Choudhury P, Kaushik SR, Arya R, et al
    Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
    Respir Res. 2020;21:126.
    PubMed     Abstract available


  50. XU W, Wang Y, Ma Y, Yang J, et al
    MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome.
    Respir Res. 2020;21:116.
    PubMed     Abstract available


  51. WEIDNER J, Ekerljung L, Malmhall C, Miron N, et al
    Circulating microRNAs correlate to clinical parameters in individuals with allergic and non-allergic asthma.
    Respir Res. 2020;21:107.
    PubMed     Abstract available


    April 2020
  52. LI W, Gao R, Xin T, Gao P, et al
    Different expression levels of interleukin-35 in asthma phenotypes.
    Respir Res. 2020;21:89.
    PubMed     Abstract available


  53. WATZ H, Hohlfeld JM, Singh D, Beier J, et al
    Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
    Respir Res. 2020;21:87.
    PubMed     Abstract available


    March 2020
  54. LANGTON D, Bennetts K, Noble P, Plummer V, et al
    Bronchial thermoplasty reduces airway resistance.
    Respir Res. 2020;21:76.
    PubMed     Abstract available


    February 2020
  55. MAO S, Wu L, Shi W
    Prevalence and distribution patterns of allergens among children with asthma and asthma-like symptoms in Shanghai, China.
    Respir Res. 2020;21:57.
    PubMed     Abstract available


  56. GOORSENBERG AWM, d'Hooghe JNS, Slats AM, van den Aardweg JG, et al
    Resistance of the respiratory system measured with forced oscillation technique (FOT) correlates with bronchial thermoplasty response.
    Respir Res. 2020;21:52.
    PubMed     Abstract available


  57. XIE M, Liu X, Cao X, Guo M, et al
    Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017.
    Respir Res. 2020;21:49.
    PubMed     Abstract available


  58. PINDUS M, Orru H, Jogi R
    Change in the symptom profile treated as asthma - two cross-sectional studies twenty years apart.
    Respir Res. 2020;21:41.
    PubMed     Abstract available


    January 2020
  59. MOUI A, Klein M, Hassoun D, Dijoux E, et al
    The IL-15 / sIL-15Ralpha complex modulates immunity without effect on asthma features in mouse.
    Respir Res. 2020;21:33.
    PubMed     Abstract available


  60. MCGEACHIE MJ, Sordillo JE, Dahlin A, Wang AL, et al
    Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy.
    Respir Res. 2020;21:31.
    PubMed     Abstract available


  61. VOGELBERG C, Goldstein S, Graham L, Kaplan A, et al
    A comparison of tiotropium, long-acting beta2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma.
    Respir Res. 2020;21:19.
    PubMed     Abstract available


  62. JIANG JX, Shen HJ, Guan Y, Jia YL, et al
    ZDHXB-101 (3',5-Diallyl-2, 4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator
    Respir Res. 2020;21:22.
    PubMed     Abstract available


  63. LIAO Y, Li P, Wang Y, Chen H, et al
    Construction of asthma related competing endogenous RNA network revealed novel long non-coding RNAs and potential new drugs.
    Respir Res. 2020;21:14.
    PubMed     Abstract available


  64. WALSCHER J, Gross B, Morisset J, Johannson KA, et al
    Comorbidities and survival in patients with chronic hypersensitivity pneumonitis.
    Respir Res. 2020;21:12.
    PubMed     Abstract available


  65. DENHOLM R, van der Werf ET, Hay AD
    Use of antibiotics and asthma medication for acute lower respiratory tract infections in people with and without asthma: retrospective cohort study.
    Respir Res. 2020;21:4.
    PubMed     Abstract available


    December 2019
  66. IBRAHIM H, O'Sullivan R, Casey D, Murphy J, et al
    The effectiveness of Reslizumab in severe asthma treatment: a real-world experience.
    Respir Res. 2019;20:289.
    PubMed     Abstract available


  67. LEAKER BR, Singh D, Lindgren S, Almqvist G, et al
    Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
    Respir Res. 2019;20:288.
    PubMed     Abstract available


  68. CHEN YF, Huang G, Wang YM, Cheng M, et al
    Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice.
    Respir Res. 2019;20:285.
    PubMed     Abstract available


  69. KIM SH, Pei QM, Jiang P, Liu J, et al
    Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma.
    Respir Res. 2019;20:282.
    PubMed     Abstract available


    November 2019
  70. VANDERS RL, Hsu A, Gibson PG, Murphy VE, et al
    Nasal epithelial cells to assess in vitro immune responses to respiratory virus infection in pregnant women with asthma.
    Respir Res. 2019;20:259.
    PubMed     Abstract available


  71. HAKANSSON KEJ, Rasmussen LJH, Godtfredsen NS, Tupper OD, et al
    The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study.
    Respir Res. 2019;20:258.
    PubMed     Abstract available


    October 2019
  72. HADDAD A, Gaudet M, Plesa M, Allakhverdi Z, et al
    Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells.
    Respir Res. 2019;20:234.
    PubMed     Abstract available


  73. HOSSEINI M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S, et al
    Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis.
    Respir Res. 2019;20:229.
    PubMed     Abstract available


  74. LIU J, Dong YQ, Yin J, Yao J, et al
    Meta-analysis of vitamin D and lung function in patients with asthma.
    Respir Res. 2019;20:161.
    PubMed     Abstract available


    September 2019
  75. BONNARDEL E, Prevel R, Campagnac M, Dubreuil M, et al
    Determination of reliable lung function parameters in intubated mice.
    Respir Res. 2019;20:211.
    PubMed     Abstract available


  76. KO FW, Chan PK, Chan RWY, Chan KP, et al
    Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease.
    Respir Res. 2019;20:210.
    PubMed     Abstract available


  77. AKIKI Z, Andrianjafimasy M, Zerimech F, Le Moual N, et al
    High level of fluorescent oxidation products and worsening of asthma control over time.
    Respir Res. 2019;20:203.
    PubMed     Abstract available


    August 2019
  78. MUNESWARAO J, Hassali MA, Ibrahim B, Saini B, et al
    It is time to change the way we manage mild asthma: an update in GINA 2019.
    Respir Res. 2019;20:183.
    PubMed     Abstract available


  79. EDRIS A, De Feyter S, Maes T, Joos G, et al
    Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.
    Respir Res. 2019;20:179.
    PubMed     Abstract available


  80. LEATHER DA, Yates L, Svedsater H, Jacques L, et al
    Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
    Respir Res. 2019;20:173.
    PubMed     Abstract available


    July 2019
  81. ALBERS FC, Papi A, Taille C, Bratton DJ, et al
    Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
    Respir Res. 2019;20:169.
    PubMed     Abstract available


  82. YANG J, Ramirez Moral I, van 't Veer C, de Vos AF, et al
    Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
    Respir Res. 2019;20:165.
    PubMed     Abstract available


  83. LIU G, Betts C, Cunoosamy DM, Aberg PM, et al
    Use of precision cut lung slices as a translational model for the study of lung biology.
    Respir Res. 2019;20:162.
    PubMed     Abstract available


  84. HALPIN DMG, Meltzer EO, Pisternick-Ruf W, Moroni-Zentgraf P, et al
    Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1.
    Respir Res. 2019;20:159.
    PubMed     Abstract available


  85. LANGTON D, Sloan G, Banks C, Bennetts K, et al
    Bronchial thermoplasty increases airway volume measured by functional respiratory imaging.
    Respir Res. 2019;20:157.
    PubMed     Abstract available


  86. PIGNATTI P, Visca D, Cherubino F, Zampogna E, et al
    Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Respir Res. 2019;20:145.
    PubMed     Abstract available


    June 2019
  87. LIU F, Qu F, Zhang H, Chao L, et al
    The effect and burden modification of heating on adult asthma hospitalizations in Shijiazhuang: a time-series analysis.
    Respir Res. 2019;20:122.
    PubMed     Abstract available


  88. GERN JE, Jackson DJ, Lemanske RF Jr, Seroogy CM, et al
    The Children's Respiratory and Environmental Workgroup (CREW) birth cohort consortium: design, methods, and study population.
    Respir Res. 2019;20:115.
    PubMed     Abstract available


    May 2019
  89. NELSEN LM, Lee LA, Wu W, Lin X, et al
    Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap.
    Respir Res. 2019;20:107.
    PubMed     Abstract available


  90. XIONG XF, Zhu M, Wu HX, Fan LL, et al
    Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.
    Respir Res. 2019;20:108.
    PubMed     Abstract available


  91. UM-BERGSTROM P, Hallberg J, Pourbazargan M, Berggren-Brostrom E, et al
    Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma.
    Respir Res. 2019;20:102.
    PubMed     Abstract available


  92. LIU L, Zhang X, Liu Y, Zhang L, et al
    Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
    Respir Res. 2019;20:95.
    PubMed     Abstract available


  93. KARMAUS W, Mukherjee N, Janjanam VD, Chen S, et al
    Distinctive lung function trajectories from age 10 to 26 years in men and women and associated early life risk factors - a birth cohort study.
    Respir Res. 2019;20:98.
    PubMed     Abstract available


  94. LI N, He Y, Yang G, Yu Q, et al
    Role of TRPC1 channels in pressure-mediated activation of airway remodeling.
    Respir Res. 2019;20:91.
    PubMed     Abstract available


  95. TRABELSI S, Casas L, Nemery B, Nawrot TS, et al
    Geographies of asthma medication purchase for pre-schoolers in Belgium.
    Respir Res. 2019;20:90.
    PubMed    


  96. PRAZMA CM, Bel EH, Price RG, Bradford ES, et al
    Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
    Respir Res. 2019;20:83.
    PubMed     Abstract available


    April 2019
  97. KANG HR, Hong SH, Ha SY, Kim TB, et al
    Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea.
    Respir Res. 2019;20:80.
    PubMed     Abstract available


    February 2019
  98. KHAKBAN A, FitzGerald JM, Tavakoli H, Lynd L, et al
    Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study.
    Respir Res. 2019;20:44.
    PubMed     Abstract available


  99. SUGAWARA H, Saito A, Yokoyama S, Tsunematsu K, et al
    Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system.
    Respir Res. 2019;20:41.
    PubMed     Abstract available


  100. ZILAEE M, Hosseini SA, Jafarirad S, Abolnezhadian F, et al
    An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial.
    Respir Res. 2019;20:39.
    PubMed     Abstract available


  101. LI HF, Yan LP, Wang K, Li XT, et al
    Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.
    Respir Res. 2019;20:38.
    PubMed     Abstract available


  102. BROWN MN, Fuhr R, Beier J, Su HL, et al
    Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial.
    Respir Res. 2019;20:37.
    PubMed     Abstract available


  103. FLEXEDER C, Zock JP, Jarvis D, Verlato G, et al
    Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey.
    Respir Res. 2019;20:33.
    PubMed     Abstract available


    January 2019
  104. ZHOU T, Huang X, Ma J, Zhou Y, et al
    Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China.
    Respir Res. 2019;20:19.
    PubMed     Abstract available


  105. ERRIAH M, Pabreja K, Fricker M, Baines KJ, et al
    Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma.
    Respir Res. 2019;20:1.
    PubMed     Abstract available


    December 2018
  106. GAFAR F, Boudewijn IM, Cox CA, Vonk JM, et al
    Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Res. 2018;19:256.
    PubMed     Abstract available


  107. NEVILLE MDC, Choi J, Lieberman J, Duan QL, et al
    Identification of deleterious and regulatory genomic variations in known asthma loci.
    Respir Res. 2018;19:248.
    PubMed     Abstract available


  108. GREGORIANO C, Dieterle T, Breitenstein AL, Durr S, et al
    Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Respir Res. 2018;19:237.
    PubMed     Abstract available


    November 2018
  109. LEWIS TC, Metitiri EE, Mentz GB, Ren X, et al
    Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children.
    Respir Res. 2018;19:228.
    PubMed     Abstract available


  110. YANG J, Luo J, Yang L, Yang D, et al
    Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review.
    Respir Res. 2018;19:217.
    PubMed     Abstract available


    October 2018
  111. COMHAIR SAA, Bochenek G, Baicker-McKee S, Wang Z, et al
    The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
    Respir Res. 2018;19:210.
    PubMed     Abstract available


  112. HAYDEN LP, Cho MH, Raby BA, Beaty TH, et al
    Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study.
    Respir Res. 2018;19:209.
    PubMed     Abstract available


  113. LO D, Kennedy JL, Kurten RC, Panettieri RA Jr, et al
    Modulation of airway hyperresponsiveness by rhinovirus exposure.
    Respir Res. 2018;19:208.
    PubMed     Abstract available


    September 2018
  114. DOMINGO C, Palomares O, Sandham DA, Erpenbeck VJ, et al
    The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.
    Respir Res. 2018;19:189.
    PubMed     Abstract available


  115. KIRENGA BJ, Mugenyi L, de Jong C, Lucian Davis J, et al
    The impact of HIV on the prevalence of asthma in Uganda: a general population survey.
    Respir Res. 2018;19:184.
    PubMed     Abstract available


  116. ZIYAB AH, Mukherjee N, Kurukulaaratchy RJ, Zhang H, et al
    Leptin receptor gene polymorphisms and sex modify the association between acetaminophen use and asthma among young adults: results from two observational studies.
    Respir Res. 2018;19:179.
    PubMed     Abstract available


  117. TONGA KO, King GG, Farah CS, Thamrin C, et al
    Steroid insensitive fixed airflow obstruction is not related to airway inflammation in older non-smokers with asthma.
    Respir Res. 2018;19:176.
    PubMed     Abstract available


  118. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Serum sST2 levels predict severe exacerbation of asthma.
    Respir Res. 2018;19:169.
    PubMed     Abstract available


  119. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Respir Res. 2018;19:168.
    PubMed     Abstract available


    August 2018
  120. MATUCCI A, Vultaggio A, Danesi R
    The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.
    Respir Res. 2018;19:154.
    PubMed     Abstract available


  121. BURBANK AJ, Todoric K, Steele P, Rosen J, et al
    Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics.
    Respir Res. 2018;19:152.
    PubMed     Abstract available


  122. ATANASOVA KR, Reznikov LR
    Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
    Respir Res. 2018;19:149.
    PubMed     Abstract available


  123. REEVES SR, Kang I, Chan CK, Barrow KA, et al
    Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts.
    Respir Res. 2018;19:146.
    PubMed     Abstract available


  124. MOHEIMANI F, Koops J, Williams T, Reid AT, et al
    Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics.
    Respir Res. 2018;19:145.
    PubMed     Abstract available


    July 2018
  125. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Abstract available


    June 2018
  126. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Abstract available


  127. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Abstract available


  128. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Abstract available


  129. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Abstract available


    May 2018
  130. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Abstract available


  131. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Abstract available


    April 2018
  132. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Abstract available


    March 2018
  133. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Abstract available


  134. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Abstract available


  135. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Abstract available


    January 2018
  136. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Abstract available


  137. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Abstract available


  138. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Abstract available


  139. MANORAK W, Idahosa C, Gupta K, Roy S, et al
    Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
    Respir Res. 2018;19:1.
    PubMed     Abstract available


    December 2017
  140. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Abstract available


  141. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Abstract available


  142. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Abstract available


  143. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Abstract available


    November 2017
  144. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Abstract available


  145. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Abstract available


  146. DESCHILDRE A, Pichavant M, Engelmann I, Langlois C, et al
    Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
    Respir Res. 2017;18:191.
    PubMed     Abstract available


  147. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Abstract available


    September 2017
  148. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Abstract available


    August 2017
  149. BLAIS CM, Davis BE, Cockcroft DW
    The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Respir Res. 2017;18:146.
    PubMed     Abstract available


    July 2017
  150. DEMARCHE SF, Schleich FN, Paulus VA, Henket MA, et al
    Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using biomarkers?
    Respir Res. 2017;18:133.
    PubMed     Abstract available


    April 2017
  151. BAKER K, Raemdonck K, Snelgrove RJ, Belvisi MG, et al
    Characterisation of a murine model of the late asthmatic response.
    Respir Res. 2017;18:55.
    PubMed     Abstract available


    February 2017
  152. BOULAY ME, Henry C, Bosse Y, Boulet LP, et al
    Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals.
    Respir Res. 2017;18:33.
    PubMed     Abstract available


    January 2017
  153. AUGUSTO LS, Silva GC, Pinho JF, Aires RD, et al
    Vascular function in asthmatic children and adolescents.
    Respir Res. 2017;18:17.
    PubMed     Abstract available


  154. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Abstract available


    November 2016
  155. KRAEMER R, Smith HJ, Sigrist T, Giger G, et al
    Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Respir Res. 2016;17:154.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: